我要投票 新华牌在医疗器械行业中的票数:180
· 外 推 电 报 ·
2025-04-27 07:40:18 星期日

【新华牌是哪个国家的品牌?】

新华牌是什么牌子?「新华牌」是 山东新华制药股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人张代铭在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力新华牌品牌出海!通过在本页面挂载新华牌品牌的产品链接和联系方式,可以提高新华牌产品曝光!跨境电商爆单神器,目前只要100元/年哦~

新华制药的前身是1943年成立于胶东抗日根据地的山东新华制药厂。公司占地近300多万平方米,现有职工4000多人。是大型制药企业、亚洲较大的解热镇痛类药物生产与出口基地,以及国内重要的心脑血管类、抗感染类及中枢神经类等药物生产企业。在我国化工及医药行业具有较高的企业地位和影响力。公司是H股、A股上市公司。目前旗下有9家控股子公司。“新华牌”商标是商务部培育和发展的出口品牌。

目前,公司年产化学原料药总量3.5万吨以上,是全球较大的安乃近、布洛芬、阿司匹林、咖啡因、左旋多巴等药物生产企业,拥有乙氧苯柳胺等10个原料药品种,制剂年生产能力为片剂达80亿片、针剂10亿支、胶囊15亿粒、颗粒剂2亿袋。生产上严把质量关,精益求精。公司是国内通过ISO9001、ISO14001、ISO10012三项认证的医药化工企业,所有在产原料药产品、制剂剂型均已通过GMP认证,茶碱、布洛芬等8个产品通过了美国FDA认证,茶碱、阿司匹林等10个产品获得了欧洲COS证书,咖啡因产品通过了美国用户的社会责任认证、环境认证,以及中国食品安全体系(HACCP)认证。同时有多个产品在俄罗斯、印度等国家完成了注册。

公司经过70多年发展,已建成总厂区、新华国际医药工业园东园、西园、新园区四大生产园区,形成了化学原料药、医药制剂、医药化工中间体、医药商业四大板块齐头并进的合理布局。未来公司将坚持以科学发展观统领全局,以四大园区、四大板块为依托,以自主创新为动力,以结构优化升级为抓手,以主导产品为龙头,以收购扩充产业链为发展策略。以药为主、精干主业,做好辅业——以房地产置业反哺制药主业的发展,做精做大原料药、医药化工中间体,突出做强制剂的发展思路。坚定不移地走科学发展、和谐发展、国际化发展之路,练内功,拓市场,调结构,增效益,实现又好又快发展,为我国医药事业发展做出新的更大的贡献!

英文翻译:The predecessor of Xinhua Pharmaceutical was established in Shandong Xinhua Pharmaceutical Factory in Jiaodong Anti Japanese base in 1943. The company covers an area of more than 3 million square meters and has more than 4000 employees. It is a large pharmaceutical enterprise, a large production and export base of antipyretic and analgesic drugs in Asia, as well as an important domestic drug manufacturer of cardio cerebrovascular, anti infective and central nervous system. It has a high status and influence in the chemical and pharmaceutical industry in China. The company is a listed company with H shares and a shares. At present, it has 9 holding subsidiaries. "Xinhua brand" is an export brand cultivated and developed by the Ministry of Commerce. At present, the company has an annual output of more than 35000 tons of chemical APIs. It is the world's largest pharmaceutical manufacturer of analgin, ibuprofen, aspirin, caffeine, levodopa and other drugs. It has 10 APIs such as ethoxybenzamide, with an annual production capacity of 8 billion tablets, 1 billion injections, 1.5 billion capsules and 200 million bags of granules. Strictly control the quality in production and keep improving. The company is a domestic pharmaceutical and chemical enterprise that has passed three certifications of ISO9001, ISO14001 and ISO10012. All the products and preparations of APIs in production have passed GMP certification. Eight products, such as theophylline and ibuprofen, have passed FDA certification in the United States. Ten products, such as theophylline and aspirin, have obtained European cos certificate. Caffeine products have passed social responsibility certification and environmental certification of American users, And China's food safety system (HACCP) certification. At the same time, many products have been registered in Russia, India and other countries. After more than 70 years of development, the company has built four production parks, namely the general plant area, the East Park, the West Park and the new park of Xinhua International Pharmaceutical Industrial Park, forming a reasonable layout of four plates, namely, chemical raw materials, pharmaceutical preparations, pharmaceutical chemical intermediates and pharmaceutical commerce. In the future, the company will adhere to the concept of scientific development to guide the overall situation, relying on four parks and four plates, with independent innovation as the driving force, with structural optimization and upgrading as the starting point, with leading products as the leader, and with acquisition and expansion of industrial chain as the development strategy. Focus on medicine, concentrate on main business, and do a good job in auxiliary business - feed back the development of the main pharmaceutical business with real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate real estate. Unswervingly follow the road of scientific development, harmonious development and international development, practice internal skill, expand market, adjust structure, increase benefit, realize sound and rapid development, and make new and greater contribution to the development of China's pharmaceutical industry!

本文链接: https://www.waitui.com/brand/7cc2179ac.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

全球首个商用智算昇腾超节点正式发布

4月26日,中国电信粤港澳大湾区智算昇腾超节点发布会,在韶关数据中心集群——中国电信粤港澳大湾区智算中心举行,全球首个商用智算昇腾超节点正式发布。(界面)

2小时前

科大讯飞发布新一代智慧课堂解决方案

4月25日,在AI赋能基础教育教学变革学术交流大会暨第五届教育装备学术大会上,科大讯飞副总裁周佳峰正式发布新一代智慧课堂解决方案,包括更新后的“星火教师助手”“AI黑板”和“AI学伴”。其中上线后的 AI 学伴,覆盖课前预习、课中学习、课后复习、精准备考、家校共育等全场景。

2小时前

全球首款三涵道穿戴式单人飞行器在杭州成功首飞

国内首创基于三涵道构型的穿戴式单人飞行器在杭州成功首飞。该飞行器由杭州智元研究院研发,续航里程≥8km,最大飞行高度≥1km,续航时间≥20min,最大速度≥60km/h。杭州智元研究院高级工程师田聪玲介绍,其采用涵道动力与舵面融合控制,有高效、可靠的特点。在人机交互方面,该飞行器可配合AR头盔和摇杆操作实现智能交互,在自动驾驶状态下能解放双手,实现高空作业。从应用看,其可应用于应急救援、飞行体验、低空经济空中作业等场景。(财联社)

2小时前

美国电商平台集体提价

近期特朗普关税政策导致全球贸易紧张局势加剧,商家运营成本上升。据美国媒体4月25日报道,美国亚马逊等电商平台上不少商家已经开始提高商品的售价。根据一家价格分析机构提供的数据,自4月9日以来,美国亚马逊网站上近1000种商品的价格出现明显上涨,涵盖服装、家居用品、电子产品和玩具等多个类别,平均涨价幅度接近30%。包括Temu、希音等多个跨境电商平台均已发布公告称,由于“近期全球贸易规则及关税变动”导致运营成本上升,将从4月25日开始实施价格调整。社交媒体上也有大量美国网友感叹道,一夜之间购物车里的东西都变贵了。 (央视财经)

2小时前

新版国家卫生监督抽查计划发布 首次明确打击网络“医托”

国家疾控局等3部门近日联合发布医疗卫生领域《2025年国家随机监督抽查计划》。相较于2024年计划,2025年计划在监管范围等方面作出调整,新增互联网诊疗、精神卫生等监管领域,并首次明确打击网络“医托”等新型违法行为,进一步强化公共卫生和医疗秩序治理。(财联社)

2小时前

本页详细列出关于新华牌的品牌信息,含品牌所属公司介绍,新华牌所处行业的品牌地位及优势。
咨询